工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Isolation and Analysis of Tumor-Infiltrating Treg.
Isolation and Analysis of Tumor-Infiltrating Treg.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
除了在免疫稳态、自身免疫和外周耐受中的重要作用外,调节性T细胞(Tregs)在癌症免疫逃逸中也发挥关键作用,通过帮助肿瘤屏蔽效应细胞介导的抗肿瘤反应。Tregs被招募浸润肿瘤,一旦在肿瘤微环境中发现有利条件,便增殖并抑制效应T细胞功能,从而促进肿瘤逃逸和生长。在人类癌症患者和小鼠模型中,效应T细胞与Tregs的低比率是这种免疫抑制性肿瘤微环境的关键特征,并与不良预后相关。本章描述了从实体瘤中分离TIL(肿瘤浸润淋巴细胞)(TILs)、对其进行定量以及通过流式细胞术进行表型分析以评估效应T细胞:Treg比率和相关标志物表达的方案。
Besides their important function in immune homeostasis, autoimmunity, and peripheral tolerance, regulatory T cells (Tregs) also play a crucial role in cancer immune evasion, by assisting tumors to shield from antitumor responses by effector cells. Tregs are recruited to infiltrate tumors and upon finding favourable conditions in the tumor microenvironment, proliferate and suppress effector T cell function thereby promoting tumor escape and growth.
In human cancer patients and mouse models, a low ratio of effector T cells to Tregs is a key feature of this immune-suppressive tumor microenvironment and correlates with poor prognosis. This chapter describes protocols for the isolation of tumor-infiltrating lymphocytes (TILs) from solid tumors, their quantification, and phenotyping via flow cytometry to assess the effector T cell:Treg ratio and the expression of relevant markers.
MEMBER ACCOUNT
登录成功会直接打开下一页。